Cerus Corporation - ROE
CERS
Price:
$2.7
Market Cap:
$541.00M
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell components. Furthermore, Cerus markets an INTERCEPT Blood System for Cryoprecipitation, which leverages its plasma technology to produce two key pathogen-reduc...[Read more]
Industry
Medical - Devices
IPO Date
1997-01-31
Stock Exchange
NASDAQ
Ticker
CERS
PE Ratio
[-54.00]
ROE
[-15.36%]
Current Ratio
[1.63]
Dividend Yield
[0%]
Enterprise Value
[610.50M]
Dividend History
The ROE as of June 2026 (TTM) for Cerus Corporation (CERS) is -15.36%
According to Cerus Corporation’s latest financial reports and current stock price. The company's current ROE is -15.36%. This represents a change of 280.35% compared to the average of -4.04% of the last 4 quarters.
Cerus Corporation (CERS) Historical ROE (quarterly & annually)
How has CERS ROE performed in the past?
The mean historical ROE of Cerus Corporation over the last ten years is -77.54%. The current -15.36% ROE has changed -80.19% with respect to the historical average. Over the past ten years (40 quarters), CERS's ROE was at its highest in in the September 2025 quarter at -0.03%. The ROE was at its lowest in in the March 2017 quarter at -44.83%.
Average
-77.54%
Median
-66.18%
Minimum
-155.59%
Maximum
-24.33%
Cerus Corporation (CERS) ROE by Quarter and Year
Discovering the peaks and valleys of Cerus Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 84.65%
Maximum Annual ROE = -24.33%
Minimum Annual Increase = -56.22%
Minimum Annual ROE = -155.59%
| Year | ROE | Change |
|---|---|---|
| 2025 | -24.33% | -34.69% |
| 2024 | -37.26% | -47.68% |
| 2023 | -71.20% | 12.53% |
| 2022 | -63.27% | -1.53% |
| 2021 | -64.26% | 11.44% |
| 2020 | -57.66% | -53.82% |
| 2019 | -124.88% | 83.35% |
| 2018 | -68.11% | -56.22% |
| 2017 | -155.59% | 42.92% |
| 2016 | -108.86% | 84.65% |
Cerus Corporation (CERS) Average ROE
How has CERS ROE performed in the past?
The current ROE of Cerus Corporation (CERS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-44.26%
5-year avg
-52.06%
10-year avg
-77.54%
Cerus Corporation (CERS) ROE vs. Peers
How is CERS’s ROE compared to its peers?
Cerus Corporation’s ROE is greater than CVRx, Inc. (-120.77%), greater than 908 Devices Inc. (-25.50%), greater than Senseonics Holdings, Inc. (-130.00%), greater than NeuroPace, Inc. (-120.74%), greater than Sight Sciences, Inc. (-59.10%), greater than Quanterix Corporation (-35.17%), less than TruBridge, Inc. (2.48%), greater than Alpha Teknova, Inc. (-24.32%), greater than RxSight, Inc. (-17.01%), greater than SANUWAVE Health, Inc. (-450.56%),
| Company | ROE | Market cap |
|---|---|---|
| -120.77% | $131.35M | |
| -25.50% | $334.65M | |
| -130.00% | $281.69M | |
| -120.74% | $532.89M | |
| -59.10% | $287.28M | |
| -35.17% | $159.69M | |
| 2.48% | $391.33M | |
| -24.32% | $280.94M | |
| -17.01% | $195.81M | |
| -450.56% | $79.20M |
Build a custom stock screener for Cerus Corporation (CERS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cerus Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cerus Corporation (CERS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cerus Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cerus Corporation's ROE?
How is the ROE calculated for Cerus Corporation (CERS)?
What is the highest ROE for Cerus Corporation (CERS)?
What is the 3-year average ROE for Cerus Corporation (CERS)?
What is the 5-year average ROE for Cerus Corporation (CERS)?
How does the current ROE for Cerus Corporation (CERS) compare to its historical average?